National Health Investors Reports Strong Q1 2026 Financial Results with Revenue and FFO Growth
summarizeSummary
National Health Investors Inc. filed its detailed Q1 2026 financial results, showing significant year-over-year increases in revenue, net income, EPS, and FFO, providing comprehensive operational and financial data.
check_boxKey Events
-
Q1 2026 Financial Results Detailed
The company furnished its Supplemental Information for the quarter ended March 31, 2026, providing comprehensive financial and operational data.
-
Significant Revenue Growth
Total revenues increased to $115.1 million in Q1 2026, up from $89.3 million in Q1 2025.
-
Diluted EPS Rises
Diluted Earnings Per Share (EPS) grew to $0.82 in Q1 2026, compared to $0.74 in the prior year's quarter.
-
Normalized FFO Per Share Increases
Normalized Funds From Operations (FFO) per diluted share rose to $1.23 in Q1 2026 from $1.15 in Q1 2025.
auto_awesomeAnalysis
This 8-K furnishes the complete Q1 2026 Supplemental Information, detailing the company's financial and operational performance for the quarter ended March 31, 2026. While preliminary Q1 results were reported via news concurrently, this filing provides the full, official financial statements and comprehensive operational metrics. The report indicates strong year-over-year growth in key areas, including total revenues, net income, diluted EPS, and Normalized FFO per diluted share. This detailed disclosure is crucial for investors to fully assess the company's health and trajectory, especially following recent strategic asset sales and CFO retirement announcements.
At the time of this filing, NHI was trading at $75.71 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $68.80 to $91.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.